Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Operating profit/ loss (EBIT) of LEO Pharma from 2008-2018

Operating profit/ loss (EBIT) of LEO Pharma from 2008 to 2018 (in million DKK)

by F. Norrestad, last edited Sep 3, 2019
Operating profit/ loss (EBIT) of LEO Pharma from 2008-2018 The Danish pharmaceutical company LEO Pharma made operating losses in 2009 and 2012, by 876 and 179 million Danish kroner, respectively. Since 2013, the company have only made operating profits, and with a significant increase in 2018 when it reached around 1.6 billion Danish kroner.
Show more

Operating profit/ loss (EBIT) of LEO Pharma from 2008 to 2018 (in million DKK)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Pharmaceutical trends in Europe"
  • Overview
The most important statistics
  • European Pharmaceutical companies
  • Self-medication market
  • Employment
  • Clinical Trials
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.